Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

HBI 2026: What healthcare must deliver by 2030

At HBI 2026, a panel featuring Andrej Babache, Managing Director, Direct Private Equity at investment firm CPP Investments,  Chenyang Xu, President and Co-Chairman at medical technology company PVmed, and James Levine, President at Foundation IPSEN, a non-profit dedicated to medical research and science communication, explored how healthcare value could be reshaped by 2030.
April 16, 2026

Affidea exits all operations in Hungary

Pan-European diagnostics and outpatient group Affidea is selling all of its Hungarian operations to Medicare Group, a Hungary-based private healthcare provider, marking a full exit from the country where it was founded in 1991.
April 16, 2026

Polypeptide Group attracts takeover interest from private equity firms

Polypeptide Group, a contract development and manufacturing organisation (CDMO) serving pharmaceutical and biotech companies, has attracted takeover interest from private equity investors. The company specialises in peptide-based active pharmaceutical ingredients (APIs) and operates manufacturing sites across the United States, Europe, and India.
April 16, 2026

H.I.G. Capital-backed Vernacare buys Eakin Surgical

Vernacare, a manufacturer of single-use medical devices and healthcare consumables backed by private equity firm H.I.G. Capital has acquired Eakin Surgical Limited from Eakin Healthcare Group, a family-owned medical device company. Eakin Surgical is a UK-based manufacturer of single-use surgical instruments.
April 16, 2026

HBI 2026: Creating value in changing times, from reactive to preventive

Healthcare systems across the world are under pressure from rising demand, ageing populations, and constrained resources. As a result, the definition of “value” in healthcare is being re-examined. Traditionally, value has meant achieving better outcomes at lower cost. At HBI 2026, a panel featuring Dimitris Moulavasilis, Group CEO at Abu Dhabi-based healthcare company M42; Pascal […]
April 16, 2026

Novo Nordisk partners with OpenAI

Danish drug maker Novo Nordisk has partnered with the American AI research organisation OpenAI to embed AI across drug development and operations, treating it as part of everyday workflows rather than a standalone project.
April 16, 2026

Revenio acquires Visionix expanding into OCT market

Revenio, a Finnish company specialising in ophthalmic diagnostics and software, has bought Visionix, a French ophthalmic technology group. The transaction values Visionix at an enterprise value of €290 million.
April 16, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us